Cellink Competitors and Similar CompaniesClear all
inviCRO's competitors and similar companies include Autolus and Centogene.
 Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. |  Centogene Centogene is a biotechnology company that provides services in the field of genetic diagnostics for rare hereditary diseases. | ||
Founding Date | Founding Date 2008 | Founding Date 2014 | Founding Date 2005 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Boston, US HQ London, GB Doylestown, US New Haven, US New Haven, US | Locations London, GB HQ London, GB | Locations Rostock, DE HQ Wien, AT Berlin, DE Frankfurt Am Main, DE Hamburg, DE Greater Noida, IN Dubai, AE see more |
Employees | Employees 1485% decrease | Employees 647 | Employees 80823% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.2 b | Valuation ($) 9.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $75.4m (FY, 2025) | Revenue (est.) €48.5m (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods $86.6m (FY, 2025) | Cost of goods €29.1m (FY, 2023) |
Gross profit | Gross profit N/A | Gross profit ($10.7m) (FY, 2025) | Gross profit €23.7m (FY, 2023) |
Net income | Net income N/A | Net income ($287.5m) (FY, 2025) | Net income (€35.5m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised $ 45.8m | Total funding raised $ 281.7m | Total funding raised $ 29.6m |
For sources of this data, please see the company profile
View Company Profiles
Autolus
HQ
London, GB
Employees
647
Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.
View companyCentogene
HQ
Rostock, DE
Employees
808↑ 23% increase
Centogene is a biotechnology company that provides services in the field of genetic diagnostics for rare hereditary diseases.
View company